{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:39:45Z","timestamp":1791311985881,"version":"4.3.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00125-008-1239-x","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T08:59:14Z","timestamp":1229936354000},"page":"385-393","source":"Crossref","is-referenced-by-count":104,"title":["The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study"],"prefix":"10.1007","volume":"52","author":[{"given":"J.","family":"Koska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Bunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Impson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"de Courten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Krakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,23]]},"reference":[{"key":"1239_CR1","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/diabetes.54.4.917","volume":"54","author":"PA Tataranni","year":"2005","unstructured":"Tataranni PA, Ortega E (2005) A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 54:917\u2013927","journal-title":"Diabetes"},{"key":"1239_CR2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s001250051058","volume":"41","author":"JC Pickup","year":"1998","unstructured":"Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241\u20131248","journal-title":"Diabetologia"},{"key":"1239_CR3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860\u2013867","journal-title":"Nature"},{"key":"1239_CR4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2337\/diabetes.51.2.455","volume":"51","author":"B Vozarova","year":"2002","unstructured":"Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:455\u2013461","journal-title":"Diabetes"},{"key":"1239_CR5","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116:1793\u20131801","journal-title":"J Clin Invest"},{"key":"1239_CR6","first-page":"337","volume":"13","author":"W Ebstein","year":"1876","unstructured":"Ebstein W (1876) Zur Therapie des Diabetes mellitus, insbesondere \u00fcber die Anwendung des salicylsauren Natron bei demselben. Berliner Klinische Wochenschrift 13:337\u2013340","journal-title":"Berliner Klinische Wochenschrift"},{"key":"1239_CR7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/bmj.2.5053.1071","volume":"2","author":"J Reid","year":"1957","unstructured":"Reid J, Macdougall AI, Andrews MM (1957) Aspirin and diabetes mellitus. BMJ 2:1071\u20131074","journal-title":"BMJ"},{"key":"1239_CR8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/bmj.1.2100.760","volume":"1","author":"RT Williamson","year":"1901","unstructured":"Williamson RT (1901) On the treatment of glycosuria and diabetes mellitus with sodium salicylate. BMJ 1:760\u2013762","journal-title":"BMJ"},{"key":"1239_CR9","first-page":"418","volume":"8","author":"A Hecht","year":"1959","unstructured":"Hecht A, Goldner MG (1959) Reappraisal of the hypoglycemic action of acetylsalicylate. Metabolism 8:418\u2013428","journal-title":"Metabolism"},{"key":"1239_CR10","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2337\/diab.27.12.1196","volume":"27","author":"P Micossi","year":"1978","unstructured":"Micossi P, Pontiroli AE, Baron SH et al (1978) Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. Diabetes 27:1196\u20131204","journal-title":"Diabetes"},{"key":"1239_CR11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0026-0495(81)90155-4","volume":"30","author":"RL Prince","year":"1981","unstructured":"Prince RL, Larkins RG, Alford FP (1981) The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects. Metabolism 30:293\u2013298","journal-title":"Metabolism"},{"key":"1239_CR12","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","volume":"109","author":"RS Hundal","year":"2002","unstructured":"Hundal RS, Petersen KF, Mayerson AB et al (2002) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109:1321\u20131326","journal-title":"J Clin Invest"},{"key":"1239_CR13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","volume":"31","author":"A Fleischman","year":"2008","unstructured":"Fleischman A, Shoelson SE, Bernier R, Goldfine AB (2008) Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31:289\u2013294","journal-title":"Diabetes Care"},{"key":"1239_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1962.03050140067017c","volume":"180","author":"SG Gilgore","year":"1962","unstructured":"Gilgore SG, Rupp JJ (1962) The long-term response of diabetes mellitus to salicylate therapy: report of a case. JAMA 180:65\u201366","journal-title":"JAMA"},{"key":"1239_CR15","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","volume":"293","author":"M Yuan","year":"2001","unstructured":"Yuan M, Konstantopoulos N, Lee J et al (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673\u20131677","journal-title":"Science"},{"key":"1239_CR16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","volume":"108","author":"JK Kim","year":"2001","unstructured":"Kim JK, Kim YJ, Fillmore JJ et al (2001) Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108:437\u2013446","journal-title":"J Clin Invest"},{"key":"1239_CR17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1677\/JOE-07-0005","volume":"195","author":"E Park","year":"2007","unstructured":"Park E, Wong V, Guan X, Oprescu AI, Giacca A (2007) Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo. J Endocrinol 195:323\u2013331","journal-title":"J Endocrinol"},{"key":"1239_CR18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1210\/jc.2005-1889","volume":"91","author":"M Mohlig","year":"2006","unstructured":"Mohlig M, Freudenberg M, Bobbert T et al (2006) Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men. J Clin Endocrinol Metab 91:964\u2013967","journal-title":"J Clin Endocrinol Metab"},{"key":"1239_CR19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/jc.2006-2491","volume":"93","author":"SN Crabben van der","year":"2008","unstructured":"van der Crabben SN, Allick G, Ackermans MT, Endert E, Romijn JA, Sauerwein HP (2008) Prolonged fasting induces peripheral insulin resistance, which is not ameliorated by high-dose salicylate. J Clin Endocrinol Metab 93:638\u2013641","journal-title":"J Clin Endocrinol Metab"},{"key":"1239_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF00291974","volume":"28","author":"PR Bratusch-Marrain","year":"1985","unstructured":"Bratusch-Marrain PR, Vierhapper H, Komjati M, Waldhausl WK (1985) Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man. Diabetologia 28:671\u2013676","journal-title":"Diabetologia"},{"key":"1239_CR21","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jcem-57-6-1102","volume":"57","author":"WP Newman","year":"1983","unstructured":"Newman WP, Brodows RG (1983) Aspirin causes tissue insensitivity to insulin in normal man. J Clin Endocrinol Metab 57:1102\u20131106","journal-title":"J Clin Endocrinol Metab"},{"key":"1239_CR22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF01228129","volume":"14","author":"D Giugliano","year":"1978","unstructured":"Giugliano D, Torella R, Siniscalchi N, Improta L, D'Onofrio F (1978) The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man. Diabetologia 14:359\u2013362","journal-title":"Diabetologia"},{"key":"1239_CR23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/smim.2000.0210","volume":"12","author":"M Karin","year":"2000","unstructured":"Karin M, Delhase M (2000) The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 12:85\u201398","journal-title":"Semin Immunol"},{"key":"1239_CR24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"MJ Yin","year":"1998","unstructured":"Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I\u03baB kinase-\u03b2. Nature 396:77\u201380","journal-title":"Nature"},{"key":"1239_CR25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"D Cai","year":"2005","unstructured":"Cai D, Yuan M, Frantz DF et al (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-\u03b2 and NF-\u03baB. Nat Med 11:183\u2013190","journal-title":"Nat Med"},{"key":"1239_CR26","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM198805123181901","volume":"318","author":"S Lillioja","year":"1988","unstructured":"Lillioja S, Mott DM, Howard BV et al (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217\u20131225","journal-title":"N Engl J Med"},{"key":"1239_CR27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1749-6632.1959.tb44923.x","volume":"82","author":"R Steele","year":"1959","unstructured":"Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420\u2013430","journal-title":"Ann N Y Acad Sci"},{"key":"1239_CR28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/diab.30.10.847","volume":"30","author":"JD Best","year":"1981","unstructured":"Best JD, Taborsky GJ, Halter JB, Porte D (1981) Glucose disposal is not proportional to plasma glucose level in man. Diabetes 30:847\u2013850","journal-title":"Diabetes"},{"key":"1239_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1172\/JCI113069","volume":"80","author":"H Yki-Jarvinen","year":"1987","unstructured":"Yki-Jarvinen H, Mott D, Young AA, Stone K, Bogardus C (1987) Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest 80:95\u2013100","journal-title":"J Clin Invest"},{"key":"1239_CR30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/dmr.5610040508","volume":"4","author":"S Lillioja","year":"1988","unstructured":"Lillioja S, Bogardus C (1988) Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev 4:517\u2013540","journal-title":"Diabetes Metab Rev"},{"key":"1239_CR31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2337\/diacare.14.7.685","volume":"14","author":"C Bogardus","year":"1991","unstructured":"Bogardus C, Lillioja S, Bennett PH (1991) Pathogenesis of NIDDM in Pima Indians. Diabetes Care 14:685\u2013690","journal-title":"Diabetes Care"},{"key":"1239_CR32","first-page":"431","volume":"14","author":"D Giugliano","year":"1988","unstructured":"Giugliano D, Cozzolino D, Ceriello A et al (1988) Studies on the mechanism of salicylate-induced increase of insulin secretion in man. Diabete Metab 14:431\u2013436","journal-title":"Diabete Metab"},{"key":"1239_CR33","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1210\/jc.2007-1212","volume":"93","author":"JM Fernandez-Real","year":"2008","unstructured":"Fernandez-Real JM, Lopez-Bermejo A, Ropero AB et al (2008) Salicylates increase insulin secretion in healthy obese subjects. J Clin Endocrinol Metab 93:2523\u20132530","journal-title":"J Clin Endocrinol Metab"},{"key":"1239_CR34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0026-0495(96)90204-8","volume":"45","author":"O Hother-Nielsen","year":"1996","unstructured":"Hother-Nielsen O, Henriksen JE, Holst JJ, Beck-Nielsen H (1996) Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. Metabolism 45:82\u201391","journal-title":"Metabolism"},{"key":"1239_CR35","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2337\/diacare.31.11.957","volume":"31","author":"D Thiebaud","year":"1982","unstructured":"Thiebaud D, Jacot E, DeFronzo RA, Maeder E, Jequier E, Felber JP (1982) The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 31:957\u2013963","journal-title":"Diabetes"},{"key":"1239_CR36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","volume":"11","author":"MC Arkan","year":"2005","unstructured":"Arkan MC, Hevener AL, Greten FR et al (2005) IKK-\u03b2 links inflammation to obesity-induced insulin resistance. Nat Med 11:191\u2013198","journal-title":"Nat Med"},{"key":"1239_CR37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1172\/JCI200418712","volume":"113","author":"M Rohl","year":"2004","unstructured":"Rohl M, Pasparakis M, Baudler S et al (2004) Conditional disruption of I\u03baB kinase 2 fails to prevent obesity-induced insulin resistance. J Clin Invest 113:474\u2013481","journal-title":"J Clin Invest"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-008-1239-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T14:26:31Z","timestamp":1550327191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-008-1239-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,23]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1007\/s00125-008-1239-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,23]]}}}